» Articles » PMID: 33499260

Bioengineering of Adenylate Cyclase Toxin for Vaccine Development and Other Biotechnological Purposes

Overview
Journal Toxins (Basel)
Publisher MDPI
Specialty Toxicology
Date 2021 Jan 27
PMID 33499260
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The adenylate cyclase toxin, CyaA, is one of the key virulent factors produced by , the causative agent of whooping cough. This toxin primarily targets innate immunity to facilitate bacterial colonization of the respiratory tract. CyaA exhibits several remarkable characteristics that have been exploited for various applications in vaccinology and other biotechnological purposes. CyaA has been engineered as a potent vaccine vehicle to deliver antigens into antigen-presenting cells, while the adenylate cyclase catalytic domain has been used to design a robust genetic assay for monitoring protein-protein interactions in bacteria. These two biotechnological applications are briefly summarized in this chapter.

Citing Articles

Development of HPV16 mouse and dog models for more accurate prediction of human vaccine efficacy.

Totain E, Lindner L, Martin N, Misseri Y, Iche A, Birling M Lab Anim Res. 2023; 39(1):14.

PMID: 37308929 PMC: 10258489. DOI: 10.1186/s42826-023-00166-3.


A Robust and Sensitive Spectrophotometric Assay for the Enzymatic Activity of Bacterial Adenylate Cyclase Toxins.

Davi M, Sadi M, Pitard I, Chenal A, Ladant D Toxins (Basel). 2022; 14(10).

PMID: 36287960 PMC: 9609896. DOI: 10.3390/toxins14100691.


Design of a Quantitative LC-MS Method for Residual Toxins Adenylate Cyclase Toxin (ACT), Dermonecrotic Toxin (DNT) and Tracheal Cytotoxin (TCT) in Vaccines.

Szymkowicz L, Gerard J, Messham B, Tam W, James D Toxins (Basel). 2021; 13(11).

PMID: 34822547 PMC: 8624556. DOI: 10.3390/toxins13110763.

References
1.
Sebo P, Fayolle C, DAndria O, Ladant D, Leclerc C, Ullmann A . Cell-invasive activity of epitope-tagged adenylate cyclase of Bordetella pertussis allows in vitro presentation of a foreign epitope to CD8+ cytotoxic T cells. Infect Immun. 1995; 63(10):3851-7. PMC: 173542. DOI: 10.1128/iai.63.10.3851-3857.1995. View

2.
Loucka J, Schlecht G, Vodolanova J, Leclerc C, Sebo P . Delivery of a MalE CD4(+)-T-cell epitope into the major histocompatibility complex class II antigen presentation pathway by Bordetella pertussis adenylate cyclase. Infect Immun. 2002; 70(2):1002-5. PMC: 127677. DOI: 10.1128/IAI.70.2.1002-1005.2002. View

3.
Preville X, Ladant D, Timmerman B, Leclerc C . Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein. Cancer Res. 2005; 65(2):641-9. View

4.
Hasan S, Rahman W, Sebo P, Osicka R . Distinct Spatiotemporal Distribution of Bacterial Toxin-Produced Cellular cAMP Differentially Inhibits Opsonophagocytic Signaling. Toxins (Basel). 2019; 11(6). PMC: 6628411. DOI: 10.3390/toxins11060362. View

5.
OBrien D, Durand D, Voegele A, Hourdel V, Davi M, Chamot-Rooke J . Calmodulin fishing with a structurally disordered bait triggers CyaA catalysis. PLoS Biol. 2017; 15(12):e2004486. PMC: 5764468. DOI: 10.1371/journal.pbio.2004486. View